M

Magellan Health Inc
F:MAH1

Watchlist Manager
Magellan Health Inc
F:MAH1
Watchlist
Price: 83.5 EUR
Market Cap: €2.2B

EV/OCF

10.3
Current
1%
More Expensive
vs 3-y average of 10.2

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
10.3
=
Enterprise Value
€1.9B
/
Operating Cash Flow
$185.4m

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
10.3
=
Enterprise Value
€1.9B
/
Operating Cash Flow
$185.4m

Valuation Scenarios

Magellan Health Inc is trading above its 3-year average

If EV/OCF returns to its 3-Year Average (10.2), the stock would be worth €82.62 (1% downside from current price).

Statistics
Positive Scenarios
3/4
Maximum Downside
-1%
Maximum Upside
+82%
Average Upside
36%
Scenario EV/OCF Value Implied Price Upside/Downside
Current Multiple 10.3 €83.5
0%
3-Year Average 10.2 €82.62
-1%
5-Year Average 10.4 €84.53
+1%
Industry Average 18.7 €151.59
+82%
Country Average 16.7 €135.39
+62%

Forward EV/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward EV/OCF

Peer Comparison

All Multiples
EV/OCF
P/E
All Countries
Close
Market Cap EV/OCF P/E
US
Magellan Health Inc
F:MAH1
2.2B EUR 10.3 8.5
US
UnitedHealth Group Inc
NYSE:UNH
321.8B USD 0 26.7
US
Anthem Inc
LSE:0HG8
88.9B USD 0 15.7
US
Elevance Health Inc
NYSE:ELV
76.4B USD 0 13.5
US
Humana Inc
NYSE:HUM
25.9B USD 0 21.8
US
Centene Corp
NYSE:CNC
20.2B USD 0 -3
US
Molina Healthcare Inc
NYSE:MOH
8.9B USD -8.8 18.9
US
Healthequity Inc
NASDAQ:HQY
6.6B USD 15.7 30.7
BR
Odontoprev SA
BOVESPA:ODPV3
8.4B BRL 13.6 14.2
US
Progyny Inc
NASDAQ:PGNY
1.5B USD 5.1 24.7
US
Clover Health Investments Corp
NASDAQ:CLOV
1.2B USD -16.8 -14.6
P/E Multiple
Earnings Growth PEG
US
M
Magellan Health Inc
F:MAH1
Average P/E: 19.4
8.5
N/A N/A
US
UnitedHealth Group Inc
NYSE:UNH
26.7
22%
1.2
US
A
Anthem Inc
LSE:0HG8
15.7
10%
1.6
US
Elevance Health Inc
NYSE:ELV
13.5
10%
1.3
US
Humana Inc
NYSE:HUM
21.8
38%
0.6
US
Centene Corp
NYSE:CNC
Negative Multiple: -3 N/A N/A
US
Molina Healthcare Inc
NYSE:MOH
18.9
14%
1.3
US
Healthequity Inc
NASDAQ:HQY
30.7
35%
0.9
BR
Odontoprev SA
BOVESPA:ODPV3
14.2
4%
3.6
US
Progyny Inc
NASDAQ:PGNY
24.7
35%
0.7
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -14.6 N/A N/A

Market Distribution

Lower than 77% of companies in the United States of America
Percentile
23rd
Based on 9 518 companies
23rd percentile
10.3
Low
0 — 11.7
Typical Range
11.7 — 23.6
High
23.6 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 11.7
Median 16.7
70th Percentile 23.6
Max 3 178 983.5

Magellan Health Inc
Glance View

Market Cap
2.2B EUR
Industry
Health Care

In the world of healthcare innovation, Magellan Health Inc. has carved a notable niche, presenting a fresh compass in navigating complex healthcare systems. Founded with a keen focus on specialized management in the healthcare industry, Magellan Health has grown into a formidable player by providing comprehensive solutions in behavioral health, specialty healthcare, and pharmacy management. The company's journey is centered around bridging gaps within the healthcare system, offering services that address mental health and substance abuse issues, emphasizing its commitment to fostering holistic well-being. By managing these critical areas, Magellan partners with payers, providers, and public sector agencies, effectively orchestrating a network that alleviates the burden of mental health challenges and optimizes patient outcomes across the board. At its core, Magellan's financial engine hums through its innovative integration of managed care programs and technology-driven solutions. It generates revenue by offering tailored solutions that help reduce costs while improving access and outcomes. Through a mix of managed care plans for specialty populations and cutting-edge digital platforms, Magellan enhances the delivery of healthcare services, ensuring they reach those who need them most. The company's business model thrives on performance-based contracts and management fees, where success is measured by its ability to improve health care quality and efficiency. By continuously investing in technology and analytics, Magellan Health not only advances its core mission but also sustains a robust economic model that remains resilient amid evolving health sector dynamics.

MAH1 Intrinsic Value
Not Available
M
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett